Saturday 17 October 2026 Export PHAR’s income statement to Excel — free account

Pharming Group N.V. Sponsored ADR

Pharming Group N.V. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 26.6% from fiscal 2024. In the quarter to June 2026, revenue fell 3.22%, EPS fell 57.1%, free cash flow fell 183.9% and total debt rose 1.55%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.36 0.27 −2.80%

Follow PHAR

Alert me

Market cap: $681.6M
P/E: 62.4×
Fwd P/E: 0.0×
Dividend yield: —
F-score: 5/9
Altman Z: 3.88
Beneish M: −2.78
Dividend safety: n/a

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	5	5	7
ROE Full definition →		0.12%	1.14%	5.10%	3.67%
ROA Full definition →		0.06%	0.63%	2.77%	2.05%
ROIC Full definition →		8.36%	8.27%	8.88%	5.50%
Return on Tangible Assets Full definition →		0.15%	1.49%	6.50%	4.83%
Average Days of Receivables Full definition →		43.93	53.08	59.31	56.75
Free Cash Flow per Share Full definition →		0.77	0.78	0.75	0.64
Free Cash Flow Full definition →		52.71	53.95	55.72	34.37
Capital Expenditures Full definition →		(0.62)	(0.75)	(0.70)	(0.66)
Other line items
Cash ROIC Full definition →		9.95%	9.72%	10.35%	6.53%
Accounts Receivable Turnover Full definition →		7.89	6.87	6.87	6.64
Accounts Payable Turnover Full definition →		0.49	0.53	0.51	0.61
Inventory Turnover Full definition →		0.57	0.75	0.71	0.76
Average Days of Payables Full definition →		779.31	849.52	862.30	609.22
Days of Inventory on Hand Full definition →		668.87	520.64	537.88	484.20
Tax Rate Full definition →		(1.00)	(0.80)	(0.39)	(0.42)
Research and Development Expense of Revenue Full definition →		25.00%	26.68%	28.36%	30.94%
Selling, General and Administrative Expense of Revenue Full definition →		58.31%	56.08%	53.98%	52.23%
Share Based Compensation of Revenue Full definition →		3.28%	3.66%	3.90%	3.90%
Operating CF/Net income Full definition →		185.18	19.19	4.57	3.74
Depreciation/Fixed assets Full definition →		2.10	1.55	1.71	1.88
Capex/Depreciation Full definition →		(0.04)	(0.07)	(0.06)	(0.05)
Revenue per Share Full definition →		5.31	5.46	4.96	6.87
Operating CF per Share Full definition →		0.78	0.79	0.76	0.66
Capex per Share Full definition →		(0.01)	(0.01)	(0.01)	(0.01)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly